nodes	percent_of_prediction	percent_of_DWPC	metapath
Tripelennamine—Tamoxifen—breast cancer	0.467	1	CrCtD
Tripelennamine—CYP2D6—breast cancer	0.149	1	CbGaD
Tripelennamine—Tamoxifen—Toremifene—breast cancer	0.027	0.0816	CrCrCtD
Tripelennamine—Doxylamine—Toremifene—breast cancer	0.0226	0.0683	CrCrCtD
Tripelennamine—Dextropropoxyphene—Toremifene—breast cancer	0.0215	0.0648	CrCrCtD
Tripelennamine—Phenoxybenzamine—Toremifene—breast cancer	0.0215	0.0648	CrCrCtD
Tripelennamine—CYP2D6—Idarubicin—breast cancer	0.0204	0.414	CbGbCtD
Tripelennamine—Bromodiphenhydramine—Toremifene—breast cancer	0.0191	0.0577	CrCrCtD
Tripelennamine—Clofedanol—Toremifene—breast cancer	0.0155	0.0469	CrCrCtD
Tripelennamine—Cyclobenzaprine—Tamoxifen—breast cancer	0.0155	0.0466	CrCrCtD
Tripelennamine—Orphenadrine—Toremifene—breast cancer	0.015	0.0454	CrCrCtD
Tripelennamine—Benzphetamine—Toremifene—breast cancer	0.015	0.0454	CrCrCtD
Tripelennamine—Doxylamine—Tamoxifen—breast cancer	0.0142	0.0429	CrCrCtD
Tripelennamine—Benzyl Benzoate—Toremifene—breast cancer	0.0139	0.042	CrCrCtD
Tripelennamine—Phenoxybenzamine—Tamoxifen—breast cancer	0.0135	0.0407	CrCrCtD
Tripelennamine—Dextropropoxyphene—Tamoxifen—breast cancer	0.0135	0.0407	CrCrCtD
Tripelennamine—Diphenhydramine—Toremifene—breast cancer	0.0133	0.0403	CrCrCtD
Tripelennamine—Dimetacrine—Tamoxifen—breast cancer	0.012	0.0362	CrCrCtD
Tripelennamine—Bromodiphenhydramine—Tamoxifen—breast cancer	0.012	0.0362	CrCrCtD
Tripelennamine—Methadone—Tamoxifen—breast cancer	0.0113	0.0341	CrCrCtD
Tripelennamine—CYP2D6—Vinorelbine—breast cancer	0.00995	0.202	CbGbCtD
Tripelennamine—Clofedanol—Tamoxifen—breast cancer	0.00975	0.0294	CrCrCtD
Tripelennamine—Orphenadrine—Tamoxifen—breast cancer	0.00944	0.0285	CrCrCtD
Tripelennamine—Benzphetamine—Tamoxifen—breast cancer	0.00944	0.0285	CrCrCtD
Tripelennamine—Promazine—Tamoxifen—breast cancer	0.00901	0.0272	CrCrCtD
Tripelennamine—CYP2D6—Tamoxifen—breast cancer	0.00898	0.183	CbGbCtD
Tripelennamine—Benzyl Benzoate—Tamoxifen—breast cancer	0.00875	0.0264	CrCrCtD
Tripelennamine—Diphenhydramine—Tamoxifen—breast cancer	0.00838	0.0253	CrCrCtD
Tripelennamine—CYP2D6—Vinblastine—breast cancer	0.00613	0.125	CbGbCtD
Tripelennamine—CYP2D6—Doxorubicin—breast cancer	0.00377	0.0766	CbGbCtD
Tripelennamine—Tamoxifen—ESRRA—breast cancer	0.000262	0.112	CrCbGaD
Tripelennamine—Rosiglitazone—SLCO1B1—breast cancer	0.000229	0.0981	CrCbGaD
Tripelennamine—Dimetacrine—ACHE—breast cancer	0.000211	0.0904	CrCbGaD
Tripelennamine—Tamoxifen—SULT1A1—breast cancer	0.000198	0.0851	CrCbGaD
Tripelennamine—Rosiglitazone—PTGS1—breast cancer	8.52e-05	0.0366	CrCbGaD
Tripelennamine—Orphenadrine—SCN10A—breast cancer	6.47e-05	0.0278	CrCbGaD
Tripelennamine—Rosiglitazone—CYP2D6—breast cancer	5.8e-05	0.0249	CrCbGaD
Tripelennamine—Mepyramine—CYP2D6—breast cancer	5.76e-05	0.0247	CrCbGaD
Tripelennamine—Tamoxifen—ESR2—breast cancer	5.58e-05	0.0239	CrCbGaD
Tripelennamine—Aprindine—CYP2D6—breast cancer	5.21e-05	0.0223	CrCbGaD
Tripelennamine—Tamoxifen—CYP1B1—breast cancer	5.09e-05	0.0218	CrCbGaD
Tripelennamine—Cyclobenzaprine—CYP2D6—breast cancer	4.43e-05	0.019	CrCbGaD
Tripelennamine—Rosiglitazone—ALB—breast cancer	4.34e-05	0.0186	CrCbGaD
Tripelennamine—Cyclobenzaprine—CYP3A4—breast cancer	3.8e-05	0.0163	CrCbGaD
Tripelennamine—Tamoxifen—CYP19A1—breast cancer	3.74e-05	0.016	CrCbGaD
Tripelennamine—Methadone—CYP19A1—breast cancer	3.71e-05	0.0159	CrCbGaD
Tripelennamine—Carbinoxamine—CYP2D6—breast cancer	3.64e-05	0.0156	CrCbGaD
Tripelennamine—Disopyramide—CYP3A4—breast cancer	3.64e-05	0.0156	CrCbGaD
Tripelennamine—Tamoxifen—ABCG2—breast cancer	3.51e-05	0.0151	CrCbGaD
Tripelennamine—Tamoxifen—ESR1—breast cancer	3.44e-05	0.0148	CrCbGaD
Tripelennamine—Bepridil—CYP2D6—breast cancer	3.22e-05	0.0138	CrCbGaD
Tripelennamine—Brompheniramine—CYP2D6—breast cancer	3.15e-05	0.0135	CrCbGaD
Tripelennamine—Carbinoxamine—CYP3A4—breast cancer	3.12e-05	0.0134	CrCbGaD
Tripelennamine—Chlorphenamine—CYP2D6—breast cancer	3.1e-05	0.0133	CrCbGaD
Tripelennamine—Diphenhydramine—PTGS1—breast cancer	3.09e-05	0.0132	CrCbGaD
Tripelennamine—Dextropropoxyphene—CYP2D6—breast cancer	2.99e-05	0.0128	CrCbGaD
Tripelennamine—Tamoxifen—CYP1A1—breast cancer	2.75e-05	0.0118	CrCbGaD
Tripelennamine—Brompheniramine—CYP3A4—breast cancer	2.71e-05	0.0116	CrCbGaD
Tripelennamine—Chlorphenamine—CYP3A4—breast cancer	2.66e-05	0.0114	CrCbGaD
Tripelennamine—Dextropropoxyphene—CYP3A4—breast cancer	2.57e-05	0.011	CrCbGaD
Tripelennamine—Bepridil—ABCB1—breast cancer	2.3e-05	0.00986	CrCbGaD
Tripelennamine—Benzphetamine—CYP3A4—breast cancer	2.25e-05	0.00965	CrCbGaD
Tripelennamine—Phenoxybenzamine—CYP3A4—breast cancer	2.15e-05	0.00922	CrCbGaD
Tripelennamine—Diphenhydramine—CYP2D6—breast cancer	2.1e-05	0.00902	CrCbGaD
Tripelennamine—Tamoxifen—CYP2D6—breast cancer	2.05e-05	0.00878	CrCbGaD
Tripelennamine—Doxepin—CYP2D6—breast cancer	2.04e-05	0.00875	CrCbGaD
Tripelennamine—Methadone—CYP2D6—breast cancer	2.03e-05	0.0087	CrCbGaD
Tripelennamine—Tamoxifen—CYP3A4—breast cancer	1.76e-05	0.00753	CrCbGaD
Tripelennamine—Doxepin—CYP3A4—breast cancer	1.75e-05	0.00751	CrCbGaD
Tripelennamine—Methadone—CYP3A4—breast cancer	1.74e-05	0.00747	CrCbGaD
Tripelennamine—Orphenadrine—CYP3A4—breast cancer	1.7e-05	0.00731	CrCbGaD
Tripelennamine—Imipramine—CYP2D6—breast cancer	1.59e-05	0.00681	CrCbGaD
Tripelennamine—Amitriptyline—CYP2D6—breast cancer	1.58e-05	0.00677	CrCbGaD
Tripelennamine—Promazine—CYP3A4—breast cancer	1.55e-05	0.00667	CrCbGaD
Tripelennamine—Tamoxifen—ABCB1—breast cancer	1.46e-05	0.00627	CrCbGaD
Tripelennamine—Doxepin—ABCB1—breast cancer	1.46e-05	0.00625	CrCbGaD
Tripelennamine—Methadone—ABCB1—breast cancer	1.45e-05	0.00622	CrCbGaD
Tripelennamine—Imipramine—CYP3A4—breast cancer	1.36e-05	0.00584	CrCbGaD
Tripelennamine—Amitriptyline—CYP3A4—breast cancer	1.35e-05	0.0058	CrCbGaD
Tripelennamine—Amitriptyline—ALB—breast cancer	1.18e-05	0.00506	CrCbGaD
Tripelennamine—Imipramine—ABCB1—breast cancer	1.13e-05	0.00486	CrCbGaD
Tripelennamine—Amitriptyline—ABCB1—breast cancer	1.13e-05	0.00483	CrCbGaD
Tripelennamine—HRH1—Signaling Pathways—SFRP2—breast cancer	1.29e-06	0.00105	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PRLR—breast cancer	1.27e-06	0.00103	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CXCL12—breast cancer	1.26e-06	0.00103	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CXCR4—breast cancer	1.26e-06	0.00103	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—breast cancer	1.26e-06	0.00103	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CDA—breast cancer	1.23e-06	0.001	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SHMT1—breast cancer	1.23e-06	0.001	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GLI2—breast cancer	1.22e-06	0.000995	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—VCP—breast cancer	1.22e-06	0.000995	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	1.22e-06	0.00099	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—LEPR—breast cancer	1.2e-06	0.000979	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—breast cancer	1.2e-06	0.000977	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLCO1B1—breast cancer	1.19e-06	0.000966	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC2A5—breast cancer	1.19e-06	0.000966	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CALCA—breast cancer	1.17e-06	0.000956	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—PIK3CA—breast cancer	1.17e-06	0.000948	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CXCL12—breast cancer	1.15e-06	0.000934	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CXCR4—breast cancer	1.15e-06	0.000934	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—APRT—breast cancer	1.15e-06	0.000933	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AGTR1—breast cancer	1.14e-06	0.00093	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—breast cancer	1.13e-06	0.000923	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ARHGDIA—breast cancer	1.12e-06	0.00091	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FST—breast cancer	1.09e-06	0.000887	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ESRRA—breast cancer	1.08e-06	0.000877	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ANGPTL4—breast cancer	1.08e-06	0.000877	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HEY2—breast cancer	1.08e-06	0.000876	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—RPS6KB2—breast cancer	1.06e-06	0.000866	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—RGS2—breast cancer	1.05e-06	0.000856	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—breast cancer	1.04e-06	0.000848	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCL20—breast cancer	1.04e-06	0.000846	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AGTR1—breast cancer	1.04e-06	0.000844	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—ITPR1—breast cancer	1.03e-06	0.000834	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HADHB—breast cancer	1.02e-06	0.000832	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GPI—breast cancer	1.02e-06	0.000832	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—LPAR1—breast cancer	1.01e-06	0.00082	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TLE3—breast cancer	1.01e-06	0.00082	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HEY1—breast cancer	9.97e-07	0.000812	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DLL1—breast cancer	9.78e-07	0.000796	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALDH7A1—breast cancer	9.75e-07	0.000794	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALDH1A1—breast cancer	9.75e-07	0.000794	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—breast cancer	9.64e-07	0.000785	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HIST1H2BC—breast cancer	9.6e-07	0.000781	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HIST1H2BK—breast cancer	9.6e-07	0.000781	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GRB7—breast cancer	9.51e-07	0.000774	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PDE4D—breast cancer	9.51e-07	0.000774	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CSF2—breast cancer	9.47e-07	0.000771	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ADSL—breast cancer	9.35e-07	0.000761	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PHGDH—breast cancer	9.35e-07	0.000761	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NME1—breast cancer	9.35e-07	0.000761	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—FHL2—breast cancer	9.35e-07	0.000761	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—UMPS—breast cancer	9.35e-07	0.000761	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TAB2—breast cancer	9.35e-07	0.000761	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—ITPR1—breast cancer	9.31e-07	0.000758	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CNR2—breast cancer	9.27e-07	0.000754	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—CXCL8—breast cancer	9.26e-07	0.000754	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—MMP3—breast cancer	9.25e-07	0.000753	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—breast cancer	9.23e-07	0.000751	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—BRIP1—breast cancer	9.17e-07	0.000746	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HPSE—breast cancer	9.17e-07	0.000746	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—LDHB—breast cancer	9.17e-07	0.000746	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DKK1—breast cancer	9.05e-07	0.000736	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—VEGFC—breast cancer	8.98e-07	0.000731	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—JAG2—breast cancer	8.84e-07	0.00072	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—WNT1—breast cancer	8.71e-07	0.000709	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PLA2G4A—breast cancer	8.69e-07	0.000708	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HMMR—breast cancer	8.69e-07	0.000707	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ABCC1—breast cancer	8.69e-07	0.000707	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTA3—breast cancer	8.69e-07	0.000707	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CSF2—breast cancer	8.6e-07	0.0007	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PPARGC1B—breast cancer	8.42e-07	0.000685	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NOTCH4—breast cancer	8.26e-07	0.000672	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GZMB—breast cancer	8.21e-07	0.000668	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CXCL2—breast cancer	7.97e-07	0.000649	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AGTR2—breast cancer	7.97e-07	0.000649	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTA4—breast cancer	7.95e-07	0.000647	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CA9—breast cancer	7.95e-07	0.000647	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PTHLH—breast cancer	7.88e-07	0.000641	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—BMP2—breast cancer	7.88e-07	0.000641	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GPX2—breast cancer	7.75e-07	0.00063	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTA2—breast cancer	7.75e-07	0.00063	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SULT1A1—breast cancer	7.65e-07	0.000623	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GPX4—breast cancer	7.65e-07	0.000623	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—EDNRB—breast cancer	7.63e-07	0.000621	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PGR—breast cancer	7.56e-07	0.000615	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—THBS1—breast cancer	7.52e-07	0.000612	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTA1—breast cancer	7.47e-07	0.000608	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—IDH1—breast cancer	7.47e-07	0.000608	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NAT2—breast cancer	7.39e-07	0.000601	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FLT1—breast cancer	7.18e-07	0.000584	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FGF3—breast cancer	7.14e-07	0.000582	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SQSTM1—breast cancer	7.14e-07	0.000582	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PIK3CG—breast cancer	7.11e-07	0.000579	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—JAG1—breast cancer	7.05e-07	0.000574	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PARP1—breast cancer	7.02e-07	0.000572	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NOTCH3—breast cancer	7.02e-07	0.000572	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CALCA—breast cancer	6.94e-07	0.000565	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—RPS6—breast cancer	6.86e-07	0.000558	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FGF4—breast cancer	6.8e-07	0.000554	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CXCL12—breast cancer	6.78e-07	0.000552	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CXCR4—breast cancer	6.78e-07	0.000552	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PAK1—breast cancer	6.65e-07	0.000541	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TCF7L2—breast cancer	6.53e-07	0.000532	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AKT2—breast cancer	6.5e-07	0.000529	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—MED12—breast cancer	6.48e-07	0.000527	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—DPYD—breast cancer	6.48e-07	0.000527	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PIK3CG—breast cancer	6.46e-07	0.000525	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALDOA—breast cancer	6.38e-07	0.000519	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HSP90AA1—breast cancer	6.3e-07	0.000513	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NOTCH2—breast cancer	6.3e-07	0.000513	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PIK3CD—breast cancer	6.25e-07	0.000509	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NCOA3—breast cancer	6.19e-07	0.000504	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC2A2—breast cancer	6.15e-07	0.0005	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PRL—breast cancer	6.13e-07	0.000499	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AGTR1—breast cancer	6.13e-07	0.000499	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ADAM10—breast cancer	6.04e-07	0.000492	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—STK11—breast cancer	6.04e-07	0.000492	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ABCG2—breast cancer	6.02e-07	0.00049	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CPT1A—breast cancer	6.02e-07	0.00049	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—MTR—breast cancer	6.02e-07	0.00049	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PLG—breast cancer	5.97e-07	0.000486	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HPGDS—breast cancer	5.91e-07	0.000481	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AKT2—breast cancer	5.91e-07	0.000481	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FGF10—breast cancer	5.88e-07	0.000478	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HBA1—breast cancer	5.87e-07	0.000478	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTT1—breast cancer	5.73e-07	0.000466	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ACHE—breast cancer	5.73e-07	0.000466	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PIK3CD—breast cancer	5.68e-07	0.000462	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PDGFA—breast cancer	5.67e-07	0.000462	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TGFBR2—breast cancer	5.59e-07	0.000455	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ITPR1—breast cancer	5.5e-07	0.000448	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—STAT5A—breast cancer	5.46e-07	0.000445	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ERBB4—breast cancer	5.46e-07	0.000445	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MMP3—breast cancer	5.46e-07	0.000445	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PIK3CB—breast cancer	5.45e-07	0.000443	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP17A1—breast cancer	5.42e-07	0.000441	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ENO1—breast cancer	5.37e-07	0.000437	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PTGS1—breast cancer	5.37e-07	0.000437	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SMAD4—breast cancer	5.29e-07	0.000431	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IGF1R—breast cancer	5.26e-07	0.000428	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CXCL8—breast cancer	5.23e-07	0.000426	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NCOA2—breast cancer	5.17e-07	0.000421	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HES1—breast cancer	5.17e-07	0.00042	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NCOR1—breast cancer	5.14e-07	0.000418	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PLA2G4A—breast cancer	5.14e-07	0.000418	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CSF2—breast cancer	5.08e-07	0.000413	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FGF1—breast cancer	5.08e-07	0.000413	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—RAF1—breast cancer	5.07e-07	0.000412	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NRG1—breast cancer	5.04e-07	0.00041	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—FASN—breast cancer	5.01e-07	0.000408	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—H2AFX—breast cancer	5.01e-07	0.000407	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—IL2—breast cancer	5e-07	0.000407	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—BCHE—breast cancer	4.99e-07	0.000406	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—E2F1—breast cancer	4.97e-07	0.000405	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PIK3CB—breast cancer	4.95e-07	0.000403	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC5A5—breast cancer	4.93e-07	0.000401	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SPP1—breast cancer	4.77e-07	0.000389	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NQO1—breast cancer	4.76e-07	0.000388	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC2A1—breast cancer	4.76e-07	0.000388	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CXCL8—breast cancer	4.75e-07	0.000387	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ERBB3—breast cancer	4.72e-07	0.000384	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FGFR2—breast cancer	4.72e-07	0.000384	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP3A4—breast cancer	4.64e-07	0.000378	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP1B1—breast cancer	4.56e-07	0.000372	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—IL2—breast cancer	4.54e-07	0.00037	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TERT—breast cancer	4.53e-07	0.000368	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HSP90AA1—breast cancer	4.48e-07	0.000364	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FGFR1—breast cancer	4.4e-07	0.000358	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NCOA1—breast cancer	4.35e-07	0.000354	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HIF1A—breast cancer	4.33e-07	0.000352	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—STK11—breast cancer	4.29e-07	0.000349	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP19A1—breast cancer	4.29e-07	0.000349	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—LEP—breast cancer	4.23e-07	0.000344	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CAV1—breast cancer	4.19e-07	0.000341	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—KDR—breast cancer	4.14e-07	0.000337	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ESR1—breast cancer	4.03e-07	0.000328	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—COMT—breast cancer	3.99e-07	0.000325	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FN1—breast cancer	3.99e-07	0.000324	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTP1—breast cancer	3.97e-07	0.000323	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NFKBIA—breast cancer	3.94e-07	0.000321	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HMOX1—breast cancer	3.92e-07	0.000319	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ITPR1—breast cancer	3.91e-07	0.000318	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NOTCH1—breast cancer	3.9e-07	0.000317	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PIK3CG—breast cancer	3.81e-07	0.00031	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—APC—breast cancer	3.81e-07	0.00031	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—KIT—breast cancer	3.81e-07	0.00031	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—EGF—breast cancer	3.77e-07	0.000307	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ABCB1—breast cancer	3.76e-07	0.000306	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—TYMS—breast cancer	3.69e-07	0.0003	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—MAPK3—breast cancer	3.65e-07	0.000297	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PLA2G4A—breast cancer	3.65e-07	0.000297	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NCOR1—breast cancer	3.65e-07	0.000297	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTM1—breast cancer	3.65e-07	0.000297	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—BRAF—breast cancer	3.58e-07	0.000292	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GPX1—breast cancer	3.49e-07	0.000284	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IGF1—breast cancer	3.49e-07	0.000284	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AKT2—breast cancer	3.49e-07	0.000284	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—EGFR—breast cancer	3.47e-07	0.000283	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP1A1—breast cancer	3.46e-07	0.000282	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ERCC2—breast cancer	3.43e-07	0.000279	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PIK3CD—breast cancer	3.35e-07	0.000273	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	3.32e-07	0.00027	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SERPINE1—breast cancer	3.32e-07	0.00027	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—KRAS—breast cancer	3.28e-07	0.000267	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—MTHFR—breast cancer	3.23e-07	0.000263	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NOS3—breast cancer	3.17e-07	0.000258	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PIK3CA—breast cancer	3.02e-07	0.000245	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MDM2—breast cancer	3e-07	0.000244	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—RAF1—breast cancer	2.99e-07	0.000244	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—RELA—breast cancer	2.98e-07	0.000243	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CAV1—breast cancer	2.97e-07	0.000242	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ERBB2—breast cancer	2.96e-07	0.000241	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MTOR—breast cancer	2.92e-07	0.000238	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PIK3CB—breast cancer	2.92e-07	0.000238	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CXCL8—breast cancer	2.81e-07	0.000229	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HRAS—breast cancer	2.79e-07	0.000227	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CDKN1B—breast cancer	2.74e-07	0.000223	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AKT1—breast cancer	2.71e-07	0.000221	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PIK3CG—breast cancer	2.71e-07	0.000221	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CASP3—breast cancer	2.69e-07	0.000219	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IL2—breast cancer	2.68e-07	0.000218	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—IL6—breast cancer	2.67e-07	0.000217	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCND1—breast cancer	2.62e-07	0.000213	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—JUN—breast cancer	2.61e-07	0.000212	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CTNNB1—breast cancer	2.59e-07	0.000211	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MMP9—breast cancer	2.54e-07	0.000207	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CDKN1A—breast cancer	2.53e-07	0.000206	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PTEN—breast cancer	2.53e-07	0.000206	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MAPK8—breast cancer	2.47e-07	0.000201	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AKT1—breast cancer	2.46e-07	0.000201	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PIK3CD—breast cancer	2.38e-07	0.000194	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALB—breast cancer	2.35e-07	0.000191	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SRC—breast cancer	2.34e-07	0.000191	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—VEGFA—breast cancer	2.28e-07	0.000186	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—STAT3—breast cancer	2.26e-07	0.000184	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NOS3—breast cancer	2.25e-07	0.000183	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MAPK3—breast cancer	2.16e-07	0.000176	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MYC—breast cancer	2.1e-07	0.000171	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TGFB1—breast cancer	2.09e-07	0.00017	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PIK3CB—breast cancer	2.08e-07	0.000169	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PTGS2—breast cancer	2.06e-07	0.000167	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—EGFR—breast cancer	2.05e-07	0.000167	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—KRAS—breast cancer	1.94e-07	0.000158	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PTEN—breast cancer	1.79e-07	0.000146	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PIK3CA—breast cancer	1.78e-07	0.000145	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TP53—breast cancer	1.72e-07	0.00014	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HRAS—breast cancer	1.65e-07	0.000134	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IL6—breast cancer	1.58e-07	0.000128	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AKT1—breast cancer	1.46e-07	0.000118	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PIK3CA—breast cancer	1.27e-07	0.000103	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—AKT1—breast cancer	1.03e-07	8.42e-05	CbGpPWpGaD
